Market Cap 29.46B
Revenue (ttm) 4.66B
Net Income (ttm) 836.30M
EPS (ttm) N/A
PE Ratio 32.17
Forward PE 29.11
Profit Margin 17.94%
Debt to Equity Ratio 0.42
Volume 4,002,900
Avg Vol 5,976,420
Day's Range N/A - N/A
Shares Out 385.87M
Stochastic %K 73%
Beta 1.45
Analysts Strong Sell
Price Target $83.85

Company Profile

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems for the management of diabetes and metabolic health in the United States and internationally. The company offers Dexcom G7 and G7 15 Day, an integrated continuous glucose monitoring system; Dexcom G6, a CGM system; Dexcom ONE+ to replace fingerstick blood glucose testing for diabetes treatment decisions; Stelo, a biosensor designed for adults with predi...

Industry: Medical Devices
Sector: Healthcare
Phone: 858 200 0200
Address:
6340 Sequence Drive, San Diego, United States
Monticello4
Monticello4 Jul. 14 at 6:01 PM
$DXCM ...
0 · Reply
Monticello4
Monticello4 Jul. 14 at 4:28 PM
$DXCM ---
0 · Reply
ETAlpha
ETAlpha Jul. 13 at 9:56 PM
$ISRG Concern heading into Thursday earnings. $ISRG has repeatedly failed to hold a strong bounce from the $400 zone. Healthcare remains strong, but medical devices are mixed and momentum stocks are under pressure. Earnings could trigger a move toward $440-$460, but weakness may open a path to $360-$380. Watching $SYK, $BSX, $DXCM. Charts tell the story before headlines do.
0 · Reply
NJ125
NJ125 Jul. 13 at 7:39 PM
$DXCM Cowen & Raymond James analyst raise target to $90. Quality control and manufacturing issues resolving . We look for nice margin increases over next 12-18 months. Do not forget partners with Oura and their investment which is going to add a lot of cash to DXCM from pending Oura IPO! Field testing of Dexcom/Aura/new AI patient specific AI-huge positive feedback IMHO. $90 on September quarterly results 👏👏
1 · Reply
Mobagri
Mobagri Jul. 13 at 6:04 PM
0 · Reply
Felaw
Felaw Jul. 10 at 8:33 PM
0 · Reply
JInvestTrade
JInvestTrade Jul. 9 at 4:00 PM
$SENS $DXCM $TNDM $ABT $PODD https://lnkd.in/p/gTqmQHT6
1 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Jul. 9 at 10:06 AM
1 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Jul. 9 at 10:06 AM
$DXCM 90% of population have these and dont know about it. root cause is insulin resistance. go to doctor and ask for thses tests or use cgm to monitor stuffs you eat and THanks me later.
0 · Reply
Felaw
Felaw Jul. 8 at 8:12 PM
0 · Reply
Latest News on DXCM
DexCom price target raised to $90 from $85 at Mizuho

2026-07-15T11:25:27.000Z - 1 hour ago

DexCom price target raised to $90 from $85 at Mizuho


DexCom initiated with a Buy at Deutsche Bank

2026-06-23T16:59:55.000Z - 21 days ago

DexCom initiated with a Buy at Deutsche Bank


DexCom initiated with a Buy at Deutsche Bank

2026-06-23T13:19:58.000Z - 21 days ago

DexCom initiated with a Buy at Deutsche Bank


Dexcom Further Advances Vision of Glucose Biosensing for All

Jun 23, 2026, 9:00 AM EDT - 21 days ago

Dexcom Further Advances Vision of Glucose Biosensing for All


The Healthcare M&A Wave

Jun 17, 2026, 12:30 PM EDT - 27 days ago

The Healthcare M&A Wave

ABT ALNY AMGN AMRX ANTX AZN BDX


DexCom price target raised to $88 from $75 at Piper Sandler

2026-06-15T10:42:11.000Z - 4 weeks ago

DexCom price target raised to $88 from $75 at Piper Sandler


FDA clears first over-the-counter glucose monitor for children

Jun 12, 2026, 4:15 PM EDT - 4 weeks ago

FDA clears first over-the-counter glucose monitor for children


DexCom price target raised to $95 from $75 at TD Cowen

2026-06-10T12:28:14.000Z - 5 weeks ago

DexCom price target raised to $95 from $75 at TD Cowen


DexCom price target raised to $85 from $75 at Mizuho

2026-06-09T11:10:24.000Z - 5 weeks ago

DexCom price target raised to $85 from $75 at Mizuho


DexCom price target raised to $91 from $81 at Raymond James

2026-06-08T19:20:09.000Z - 5 weeks ago

DexCom price target raised to $91 from $81 at Raymond James


DexCom announces results from CONNECT trial of Dexcom G7

2026-06-07T22:00:07.000Z - 5 weeks ago

DexCom announces results from CONNECT trial of Dexcom G7


DexCom price target raised to $90 from $85 at Stifel

2026-06-05T11:09:50.000Z - 5 weeks ago

DexCom price target raised to $90 from $85 at Stifel


DexCom price target raised to $84 from $79 at Citi

2026-05-28T12:20:33.000Z - 6 weeks ago

DexCom price target raised to $84 from $79 at Citi


DexCom identifies theft of scrapped Dexcom G7 sensors

2026-05-26T16:46:26.000Z - 7 weeks ago

DexCom identifies theft of scrapped Dexcom G7 sensors


Dexcom warns patients as stolen glucose sensors hit the market

May 26, 2026, 10:47 AM EDT - 7 weeks ago

Dexcom warns patients as stolen glucose sensors hit the market


DexCom announces Dexcom Flex in Germany

2026-05-18T11:48:09.000Z - 2 months ago

DexCom announces Dexcom Flex in Germany


DexCom price target lowered to $80 from $100 at BofA

2026-05-18T11:28:09.000Z - 2 months ago

DexCom price target lowered to $80 from $100 at BofA


DexCom price target lowered to $82 from $100 at Canaccord

2026-05-18T11:10:49.000Z - 2 months ago

DexCom price target lowered to $82 from $100 at Canaccord


DexCom price target lowered to $64 from $67 at Barclays

2026-05-18T09:46:16.000Z - 2 months ago

DexCom price target lowered to $64 from $67 at Barclays


DexCom Transcript: Investor Day 2026

May 14, 2026, 4:15 PM EDT - 2 months ago

DexCom Transcript: Investor Day 2026


DexCom Slides: FY 2026

May 14, 2026, 4:15 PM EDT - 2 months ago

DexCom Slides: FY 2026


Dexcom to Host Investor Day on May 14, 2026

May 5, 2026, 8:30 AM EDT - 2 months ago

Dexcom to Host Investor Day on May 14, 2026


DexCom Earnings Call Transcript: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 2 months ago

DexCom Earnings Call Transcript: Q1 2026


DexCom Earnings release: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 2 months ago

DexCom Earnings release: Q1 2026


DexCom Slides: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 2 months ago

DexCom Slides: Q1 2026


DexCom Quarterly report: Q1 2026

Apr 30, 2026, 4:30 PM EDT - 2 months ago

DexCom Quarterly report: Q1 2026


Dexcom Reports First Quarter 2026 Financial Results

Apr 30, 2026, 4:02 PM EDT - 2 months ago

Dexcom Reports First Quarter 2026 Financial Results


DexCom Slides: Investor presentation

Apr 30, 2026, 7:00 AM EDT - 2 months ago

DexCom Slides: Investor presentation


DexCom Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 3 months ago

DexCom Proxy statement: Proxy filing


DexCom Proxy statement: Proxy filing

Apr 15, 2026, 8:00 AM EDT - 3 months ago

DexCom Proxy statement: Proxy filing


Dexcom Appoints Rick Osterloh to Board of Directors

Feb 26, 2026, 4:15 PM EST - 4 months ago

Dexcom Appoints Rick Osterloh to Board of Directors


Dexcom Announces Upcoming Conference Presentation

Feb 25, 2026, 8:30 AM EST - 4 months ago

Dexcom Announces Upcoming Conference Presentation


The Big 3: VZ, DXCM, AMAT

Feb 19, 2026, 1:00 PM EST - 5 months ago

The Big 3: VZ, DXCM, AMAT

AMAT VZ


DexCom Earnings Call Transcript: Q4 2025

Feb 12, 2026, 4:30 PM EST - 5 months ago

DexCom Earnings Call Transcript: Q4 2025


DexCom Annual report: Q4 2025

Feb 12, 2026, 4:30 PM EST - 5 months ago

DexCom Annual report: Q4 2025


DexCom Earnings release: Q4 2025

Feb 12, 2026, 4:30 PM EST - 5 months ago

DexCom Earnings release: Q4 2025


DexCom Slides: Q4 2025

Feb 12, 2026, 4:30 PM EST - 5 months ago

DexCom Slides: Q4 2025


DexCom Slides: Investor presentation

Feb 12, 2026, 7:00 AM EST - 5 months ago

DexCom Slides: Investor presentation


Watch CNBC's exclusive interview with Dexcom CEO Jake Leach

Jan 13, 2026, 5:24 PM EST - 6 months ago

Watch CNBC's exclusive interview with Dexcom CEO Jake Leach


DexCom Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 10:30 AM EST - 6 months ago

DexCom Transcript: 44th Annual J.P. Morgan Healthcare Conference


DexCom Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 12, 2026, 10:30 AM EST - 6 months ago

DexCom Slides: 44th Annual J.P. Morgan Healthcare Conference


Monticello4
Monticello4 Jul. 14 at 6:01 PM
$DXCM ...
0 · Reply
Monticello4
Monticello4 Jul. 14 at 4:28 PM
$DXCM ---
0 · Reply
ETAlpha
ETAlpha Jul. 13 at 9:56 PM
$ISRG Concern heading into Thursday earnings. $ISRG has repeatedly failed to hold a strong bounce from the $400 zone. Healthcare remains strong, but medical devices are mixed and momentum stocks are under pressure. Earnings could trigger a move toward $440-$460, but weakness may open a path to $360-$380. Watching $SYK, $BSX, $DXCM. Charts tell the story before headlines do.
0 · Reply
NJ125
NJ125 Jul. 13 at 7:39 PM
$DXCM Cowen & Raymond James analyst raise target to $90. Quality control and manufacturing issues resolving . We look for nice margin increases over next 12-18 months. Do not forget partners with Oura and their investment which is going to add a lot of cash to DXCM from pending Oura IPO! Field testing of Dexcom/Aura/new AI patient specific AI-huge positive feedback IMHO. $90 on September quarterly results 👏👏
1 · Reply
Mobagri
Mobagri Jul. 13 at 6:04 PM
0 · Reply
Felaw
Felaw Jul. 10 at 8:33 PM
0 · Reply
JInvestTrade
JInvestTrade Jul. 9 at 4:00 PM
$SENS $DXCM $TNDM $ABT $PODD https://lnkd.in/p/gTqmQHT6
1 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Jul. 9 at 10:06 AM
1 · Reply
CmonManGiveMeABreak
CmonManGiveMeABreak Jul. 9 at 10:06 AM
$DXCM 90% of population have these and dont know about it. root cause is insulin resistance. go to doctor and ask for thses tests or use cgm to monitor stuffs you eat and THanks me later.
0 · Reply
Felaw
Felaw Jul. 8 at 8:12 PM
0 · Reply
Felaw
Felaw Jul. 8 at 2:45 PM
0 · Reply
JInvestTrade
JInvestTrade Jul. 8 at 5:33 AM
$SENS $DXCM $ABBV $TNDM $PODD https://lnkd.in/p/gEzezxjR
0 · Reply
JInvestTrade
JInvestTrade Jul. 8 at 5:31 AM
$SENS $DXCM https://lnkd.in/p/gpddsAGg
0 · Reply
Felaw
Felaw Jul. 7 at 7:52 PM
0 · Reply
SunshineTiger
SunshineTiger Jul. 7 at 4:42 PM
$DXCM To Jake and his Dexcom family. This is how it feels when you G6 sunsets into G7. It feels like shit Jake, of course G7 looks cooler (I mean it's so sexy slimmer and smaller) but when when your health is on the line does that really matter? ...Think fast... Function over Fashion is lost on "Jakes Team" I know what "Pathetic Selloutism" looks like, and G7 hits that mark perfectly. G7's fails to communicate across the body as a result of G7's weaker transmitter. I called Dexcom technical this morning to confirm and yes it fails across the body with Omnipod. Dexcom suggests wearing your Omnipod on you stomach while the Dexcom patch is on your arm. But that really interfere's with ones C.C withdrawal, and I won't be having it. Enjoy investing here, what a joke. Real recognizes Real. Jake you sir have failed being that.
3 · Reply
Felaw
Felaw Jul. 7 at 4:16 PM
0 · Reply
BillionerOfKing
BillionerOfKing Jul. 6 at 11:10 PM
$DXCM Current Stock Price: $72.39 Contracts to trade: $72.0 DXCM Jul 10 2026 Call Entry: $1.40 Exit: $1.97 ROI: 41% Hold ~28 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
ortega1963
ortega1963 Jul. 6 at 6:54 PM
$DXCM This week EMA 50 needs to cross above the EMA 200
0 · Reply
Optimist420
Optimist420 Jul. 6 at 4:13 PM
$CURLF Adding CURLF today on this dip. I'm actually averaging down. Every day we're closer to the floodgates opening. S3 is a big deal..don't miss it. 🦬 $DXCM $COIN $SHOP
2 · Reply
JackDarwin
JackDarwin Jul. 2 at 1:23 PM
$DXCM Bullish Harami Candlestick Pattern Formed at Downtrend
0 · Reply
Punpire
Punpire Jul. 1 at 8:15 PM
$SENS Using the Eversense 365 compared to the $DXCM G7 feels like this Add for Black Rifle Coffee Company. Senseonics needs to hire who ever the Marketing person is for Black Rifle. https://youtu.be/PTHoW447564
0 · Reply